SECUKINUMAB RETREATMENT SHOWS RAPID RECAPTURE OF TREATMENT RESPONSE: AN ANALYSIS OF A PHASE 3 EXTENSION TRIAL IN PSORIASIS

被引：0

作者：

Blauvelt, A. ^{[1
]}

Reich, K. ^{[2
,3
]}

Warren, R. ^{[4
,5
]}

Sigurgeirsson, B. ^{[6
]}

Langley, R. ^{[7
]}

Papavassilis, C. ^{[8
]}

Frueh, J. ^{[8
]}

Messina, I ^{[8
]}

Bhosekar, V ^{[9
]}

Oliver, J. ^{[8
]}

机构：

[1] Oregon Med Res Ctr, Portland, OR USA

[2] Dermatologikum Hamburg, Hamburg, Germany

[3] Georg August Univ, Gottingen, Germany

[4] Univ Manchester, Dermatol Ctr, Manchester, Lancs, England

[5] Univ Manchester, Manchester, Lancs, England

[6] Univ Iceland, Reykjavik, Iceland

[7] Dalhousie Univ, Halifax, NS, Canada

[8] Novartis Pharma Ag, Basel, Switzerland

[9] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

0231

引用

页码：1264 / 1265

页数：2